TENAX THERAPEUTICS, INC. (TENX) › Cash & EquivalentsTENAX THERAPEUTICS, INC. (TENX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.1967: $02010: $632.7K2011: $951.9K2012: $1.88M2013: $783.5K2014: $58.32M2015: $3.66M2016: $10.00M2017: $1.60M2018: $12.37M2019: $4.91M2020: $6.25M2021: $5.58M2022: $2.12M2023: $9.80M2024: $94.90M2025: $97.60M$97.60M1967Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$97.60M+2.8%2024$94.90M+868.4%2023$9.80M+361.5%2022$2.12M-62.0%2021$5.58M-10.7%2020$6.25M+27.4%2019$4.91M-60.3%2018$12.37M+670.6%2017$1.60M-83.9%2016$10.00M+173.1%2015$3.66M-93.7%2014$58.32M+7343.3%2013$783.5K-58.3%2012$1.88M+97.5%2011$951.9K+50.5%2010$632.7K—1967$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share